Kwality Pharmaceuticals
Kwality Pharmaceuticals Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Kwality Pharmaceuticals
Start SIPKwality Pharmaceuticals Investment Rating
-
Master Rating:
-
M K Proteins has an operating revenue of Rs. 660.58 Cr. on a trailing 12-month basis. An annual revenue growth of 23% is outstanding, Pre-tax margin of 5% is okay, ROE of 21% is exceptional. The company has a reasonable debt to equity of 5%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 6% and 20% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 45 which is a POOR score indicating inconsistency in earnings, a RS Rating of 51 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 136 indicates it belongs to a poor industry group of Food-Packaged and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 70 | 67 | 69 | 56 | 56 | 70 | 64 |
Operating Expenses Qtr Cr | 54 | 54 | 57 | 41 | 40 | 52 | 48 |
Operating Profit Qtr Cr | 15 | 14 | 12 | 15 | 16 | 18 | 16 |
Depreciation Qtr Cr | 5 | 5 | 4 | 4 | 4 | 3 | 3 |
Interest Qtr Cr | 2 | 2 | 2 | 2 | 1 | 1 | 1 |
Tax Qtr Cr | 2 | 2 | -2 | 3 | 2 | 4 | 4 |
Net Profit Qtr Cr | 6 | 5 | -7 | 7 | 9 | 11 | 10 |
Kwality Pharmaceuticals Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹368.10
- 50 Day
- ₹360.15
- 100 Day
- ₹354.96
- 200 Day
- ₹353.20
- 20 Day
- ₹362.78
- 50 Day
- ₹354.17
- 100 Day
- ₹361.21
- 200 Day
- ₹338.49
Kwality Pharmaceuticals Resistance and Support
Resistance | |
---|---|
First Resistance | 385.10 |
Second Resistance | 397.40 |
Third Resistance | 404.95 |
RSI | 54.27 |
MFI | 74.46 |
MACD Single Line | 7.92 |
MACD | 9.39 |
Support | |
---|---|
First Resistance | 365.25 |
Second Resistance | 357.70 |
Third Resistance | 345.40 |
Kwality Pharmaceuticals Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 9,092 | 667,807 | 73.45 |
Week | 14,462 | 938,847 | 64.92 |
1 Month | 15,477 | 1,174,888 | 75.91 |
6 Month | 26,969 | 2,079,873 | 77.12 |
Kwality Pharmaceuticals Result Highlights
Kwality Pharmaceuticals Synopsis
NSE-Food-Packaged
M K Proteins belongs to the Industry of Edible Oils & Solvent Extraction. Company’s Total Operating Revenue is Rs. 314.86 Cr. and Equity Capital is Rs. 12.51 Cr. for the Year ended 31/03/2023. M K Proteins Ltd. is a Public Limited Listed company incorporated on 15/06/2012 and has its registered office in the State of Haryana, India. Company’s Corporate Identification Number(CIN) is L15500HR2012PLC046239 and registration number is 046239.Market Cap | 1,119 |
Sales | 405 |
Shares in Float | 3.13 |
No of funds | 1 |
Yield |
Book Value | 22.09 |
U/D Vol ratio | 1.2 |
LTDebt / Equity | 5 |
Alpha | 0.16 |
Beta | -0.22 |
Kwality Pharmaceuticals
Owner Name | Sep-23 | Jun-23 | Mar-23 | Feb-23 |
---|---|---|---|---|
Promoters | 74.82% | 74.82% | 74.82% | 74.82% |
Foreign Portfolio Investors | ||||
Individual Investors | 12.27% | 11.56% | 11.47% | 11.45% |
Others | 12.91% | 13.62% | 13.71% | 13.73% |
Kwality Pharmaceuticals Management
Name | Designation |
---|---|
Mr. Vinod Kumar | Managing Director & CEO |
Mr. Raj Kumar | Whole Time Director |
Mr. Parvind Kumar | Non Executive Director |
Mr. Parmod Kumar | Non Executive Director |
Mr. Chatter Singh | Ind. Non-Executive Director |
Mr. Raman Kumar Sah | Ind. Non-Executive Director |
Mr. Abhay Kumar | Ind. Non-Executive Director |
Mr. Dinesh Singh Malik | Ind. Non-Executive Director |
Ms. Laxmi Mandal | Ind. Non-Executive Director |
Kwality Pharmaceuticals Forecast
Price Estimates
Kwality Pharmaceuticals Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-11-04 | Quarterly Results | |
2023-08-10 | Quarterly Results | |
2023-05-27 | Audited Results | |
2023-02-14 | Quarterly Results | |
2022-11-14 | Quarterly Results |
Kwality Pharmaceuticals FAQs
What is Share Price of Kwality Pharmaceuticals ?
Kwality Pharmaceuticals share price is ₹371 As on 06 December, 2023 | 16:38
What is the Market Cap of Kwality Pharmaceuticals ?
The Market Cap of Kwality Pharmaceuticals is ₹385 Cr As on 06 December, 2023 | 16:38
What is the P/E ratio of Kwality Pharmaceuticals ?
The P/E ratio of Kwality Pharmaceuticals is 33.7 As on 06 December, 2023 | 16:38
What is the PB ratio of Kwality Pharmaceuticals ?
The PB ratio of Kwality Pharmaceuticals is 1.9 As on 06 December, 2023 | 16:38